NCT00882102 2013-09-13Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)M.D. Anderson Cancer CenterPhase 2 Completed43 enrolled 5 charts
NCT00968071 2013-03-08Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic SyndromeM.D. Anderson Cancer CenterPhase 2 Completed71 enrolled 5 charts